BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17634782)

  • 1. How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.
    Bush TM; Bonomi AE; Nekhlyudov L; Ludman EJ; Reed SD; Connelly MT; Grothaus LC; LaCroix AZ; Newton KM
    J Gen Intern Med; 2007 Sep; 22(9):1311-6. PubMed ID: 17634782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' and women's views on hormone therapy and breast cancer risk after the WHI: a qualitative study.
    Nekhlyudov L; Bush T; Bonomi AE; Ludman EJ; Newton KM
    Women Health; 2009 Jun; 49(4):280-93. PubMed ID: 19753504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' and clinicians' attitudes after the Women's Health Initiative study.
    Blümel JE; Castelo-Branco C; Chedraui PA; Binfa L; Dowlani B; Gómez MS; Sarrá S
    Menopause; 2004; 11(1):57-61. PubMed ID: 14716183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
    Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
    Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative.
    Lakey SL; Reed SD; LaCroix AZ; Grothaus L; Newton KM
    J Womens Health (Larchmt); 2010 Dec; 19(12):2175-81. PubMed ID: 21062201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre.
    Natari RB; Hollingworth SA; Clavarino AM; Dingle KD; McGuire TM
    BMC Womens Health; 2021 Oct; 21(1):348. PubMed ID: 34607596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone therapy following the Women's Health Initiative (WHI) study: perception of gynecologists in Brazil.
    Machado RB; Fernandes CE; Maia E; Melo NR; Baracat EC
    Minerva Ginecol; 2005 Oct; 57(5):563-8. PubMed ID: 16205602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA; Wee CC
    J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the WHI study on the attitude of Israeli gynecologists to hormonal therapy during menopause.
    Kaplan B; Yogev Y; Orvieto R; Hirsch M; Fisher M; Rabinerson D
    Clin Exp Obstet Gynecol; 2004; 31(4):267-8. PubMed ID: 15672962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany.
    Heitmann C; Greiser E; Dören M
    Menopause; 2005; 12(4):405-11. PubMed ID: 16037755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative.
    Lukes A
    J Manag Care Pharm; 2008 Apr; 14(3 Suppl):7-13. PubMed ID: 18439061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2017 Women's Health Initiative study and use of hormone therapy: an emulated repeated cross-sectional study.
    Chueh CH; Ho PK; Li WH; Shiu MN; Wang IT; Wen YW; Tsai YW
    BMC Public Health; 2024 Jun; 24(1):1674. PubMed ID: 38914983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy.
    Taylor HS; Kagan R; Altomare CJ; Cort S; Bushmakin AG; Abraham L
    Menopause; 2017 Jan; 24(1):27-34. PubMed ID: 27575548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles.
    Fugh-Berman A; McDonald CP; Bell AM; Bethards EC; Scialli AR
    PLoS Med; 2011 Mar; 8(3):e1000425. PubMed ID: 21423581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The woman patient after WHI.
    Graziottin A
    Maturitas; 2005 May; 51(1):29-37. PubMed ID: 15883106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and perception of hormone therapy following media reports of the Women's Health Initiative: a survey of Australian WISDOM participants.
    Paine BJ; Stocks NP; Ramsay EN; Ryan P; MacLennan AH;
    Climacteric; 2004 Jun; 7(2):143-52. PubMed ID: 15497903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.